The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BMX inhibition and HSD3B1-driven resistance in prostate cancer in the Maverick trial.
 
Nima Sharifi
Consulting or Advisory Role - Roivant
Research Funding - Astellas Pharma (Inst); Bristol Myers Squibb Foundation (Inst)
Patents, Royalties, Other Intellectual Property - A patent application has been filed by Cleveland Clinic for a method of steroid-dependent disease treatment based on HSD3B1. Nima Sharifi is a co-inventor on this patent application
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Exelixis; Janssen; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Sorrento Therapeutics; Tempus; Vividion Therapeutics
Research Funding - Bayer (Inst); Pfizer (Inst); Tempus (Inst)
 
Jake Vinson
No Relationships to Disclose
 
Mike A. Royal
Employment - Sorrento Therapeutics
Leadership - Sorrento Therapeutics
Stock and Other Ownership Interests - Sorrento Therapeutics
 
Joshua Michael Lang
Stock and Other Ownership Interests - Salus Discovery
Consulting or Advisory Role - 4D Pharma; 4D Pharma; Arvinas; AstraZeneca; Gilead Sciences; Immunomedics; Janssen; Pfizer/Astellas; Pfizer/Myovant; Sanofi; Sanofi
Research Funding - Agensys (Inst); Arvinas (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.
 
Eric A. Klein
Consulting or Advisory Role - Genomic Health; GRAIL
 
Xiuxiu Li
No Relationships to Disclose
 
Michael Berk
No Relationships to Disclose
 
Christopher Goins
No Relationships to Disclose
 
Mohammad Alyamani
No Relationships to Disclose
 
Yoon-Mi Chung
No Relationships to Disclose
 
Chenyao Wang
No Relationships to Disclose
 
Mona Patel
No Relationships to Disclose
 
Nityam Rathi
No Relationships to Disclose
 
Ziqi Zhu
No Relationships to Disclose
 
Belinda Willard
No Relationships to Disclose
 
Shaun Stauffer
No Relationships to Disclose